{"context":{"query":">>hgnc>>gencc","source_dataset":"hgnc","target_dataset":"gencc"},"stats":{"queried":1,"total":11,"mapped":1},"pagination":{"has_next":false},"schema":"id|gene_symbol|disease_title|classification_title|moi_title|submitter_title","mappings":[{"input":"HGNC:1101","source":"HGNC:1101|BRCA2 DNA repair associated","targets":["GENCC_000101-HGNC_1101-OMIM_155255-HP_0000006-GENCC_100004|BRCA2|medulloblastoma|Limited|Autosomal dominant|Ambry Genetics","GENCC_000101-HGNC_1101-OMIM_605724-HP_0000007-GENCC_100001|BRCA2|Fanconi anemia complementation group D1|Definitive|Autosomal recessive|Ambry Genetics","GENCC_000101-HGNC_1101-OMIM_612555-HP_0000006-GENCC_100001|BRCA2|breast-ovarian cancer, familial, susceptibility to, 2|Definitive|Autosomal dominant|Ambry Genetics","GENCC_000104-HGNC_1101-MONDO_0005089-HP_0000006-GENCC_100003|BRCA2|sarcoma|Moderate|Autosomal dominant|Genomics England PanelApp","GENCC_000104-HGNC_1101-OMIM_612555-HP_0000006-GENCC_100002|BRCA2|breast-ovarian cancer, familial, susceptibility to, 2|Strong|Autosomal dominant|Genomics England PanelApp","GENCC_000104-HGNC_1101-OMIM_613347-HP_0000006-GENCC_100002|BRCA2|pancreatic cancer, susceptibility to, 2|Strong|Autosomal dominant|Genomics England PanelApp","GENCC_000106-HGNC_1101-OMIM_605724-HP_0000007-GENCC_100002|BRCA2|Fanconi anemia complementation group D1|Strong|Autosomal recessive|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_1101-OMIM_612555-HP_0000006-GENCC_100002|BRCA2|breast-ovarian cancer, familial, susceptibility to, 2|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000110-HGNC_1101-ORPHANET_145-HP_0000006-GENCC_100009|BRCA2|hereditary breast ovarian cancer syndrome|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_1101-ORPHANET_84-HP_0000007-GENCC_100009|BRCA2|Fanconi anemia|Supportive|Autosomal recessive|Orphanet","GENCC_000112-HGNC_1101-OMIM_605724-HP_0000007-GENCC_100001|BRCA2|Fanconi anemia complementation group D1|Definitive|Autosomal recessive|G2P"]}]}